High-risk plaque (HRP) features as detected by coronary computed tomography angiography (CTA) predict acute coronary syndrome (ACS). We sought to determine whether coronary CTAspecific definitions of HRP improve discrimination of patients with ACS as compared with definitions from intravascular ultrasound (IVUS).
M
orphological characteristics of coronary plaques called high-risk plaque (HRP) features are associated with culprit lesion of acute coronary syndrome (ACS) and provide incremental prognostic value over clinical risk factors and significant coronary artery stenosis. [1] [2] [3] [4] [5] [6] In intravascular ultrasound (IVUS), the presence of thin-cap fibroatheroma (TCFA), 7 minimal luminal area (MLA) ≤4.0 mm 2 , 7-10 remodeling index (RI) >1.05, 11, 12 and plaque burden ≥70% 7 are frequently used thresholds to identify coronary plaque associated with increased risk for cardiovascular events. 7, 13, 14 Coronary computed tomography angiography (CTA) is a reasonable modality to approach patients with suspected ACS [15] [16] [17] because of its high accuracy to detect coronary artery stenosis and its ability to visualize atherosclerosis. [18] [19] [20] Moreover, coronary CTA provides detailed information about plaque morphology and composition [1] [2] [3] 21 and may become the main diagnostic tool for noninvasive plaque characterization.
Spatial and temporal resolution and ability for tissue characterization of coronary CTA and IVUS differ significantly. However, specific definitions for HRP do not exist for coronary CTA, and definitions from IVUS have been used previously. In coronary CTA, plaque characteristics can be assessed not only qualitatively but also quantitatively, which has been validated extensively against IVUS. 5, [22] [23] [24] Novel software applications now permit (semi) automated assessment and quantification of coronary plaque, which has been shown to be feasible 25 and valuable. 26 The performance of IVUS definitions for HRP features detected by coronary CTA is unknown, and independently derived thresholds of HRP feature from coronary CTA are not available. Therefore, we performed CTA-based quantitative analyses in patients presenting with acute chest pain and sought to derive optimized CTA-specific definitions of HRP features for the prediction of ACS. We tested whether there was a difference between IVUS-based and CTA-specific thresholds and whether CTA-specific HRP definitions improved the discrimination of patients with ACS.
MATERIALS AND METHODS

Study Design and Patient Population
The study cohort consisted of patients from the ROMICAT (Rule Out Myocardial Infarction/Ischemia Using Computer Assisted Tomography) II trial. Individuals, who were randomly assigned to the coronary CTA arm and underwent CTA, were included in this analysis. A detailed description of the patient population was previously reported. 15 In summary, this multicenter trial (9 sites in the United States) enrolled 1000 patients with acute chest pain and clinical suspicion for ACS presenting to the emergency department between April 2010 and January 2012. Enrollment criteria were 40 to 74 years of age, negative initial cardiac troponin, and ECG without ischemic changes. All study participants provided written informed consent for participation in the ROMICAT II trial, and the local institutional review boards approved the study.
Computed Tomography Image Acquisition and Analysis
For the acquisition of coronary CTA images, either retrospectively ECG-gated or prospectively ECG-triggered protocols were used with at least 64-mutidetector row computed tomography technology. Each data set was analyzed by 1 of 4 readers with at least 5 years of experience and level III training in coronary CTA. Quantitative plaque analysis was performed using a dedicated workstation and coronary plaque analysis software (QAngio CT RE 2.0, Medis medical imaging systems b.v., Leiden, the Netherlands). Data sets were randomly assigned in equal parts to all 4 readers. All readers analyzed 20 randomly selected coronary CTA data sets to calculate interobserver variability.
The quantitative plaque analysis was performed on coronary segment basis in all segments with visually detectable plaques. Segments with image quality graded as nondiagnostic were excluded from the analysis (n=108/3804). The readers followed a stepwise procedure as displayed in Figure 1 and Figures I to V in the Data Supplement: (1) major coronary arteries were automatically identified, (2) luminal and outer vessel boundaries were automatically delineated by the software, (3) the readers performed manual adjustments of boundaries if necessary, and (4) the proximal and distal ends of the coronary plaque was chosen where normal artery could be identified at the proximal and distal sites or at the beginning and end of the coronary segment if no normal artery was identified in the segment.
CLINICAL PERSPECTIVE
Marked differences in plaque extent and morphology can be detected in culprit as compared with nonculprit plaques by coronary computed tomography angiography in patients with acute coronary syndrome. In our analysis, we found that the presence of high-risk plaque features based on intravascular ultrasound definitions had good diagnostic accuracy for the detection of acute coronary syndrome. However, we demonstrated significant differences and higher accuracy of independently derived optimized coronary computed tomography angiography-specific high-risk plaque feature definitions, suggesting improvement in discrimination of patients with acute coronary syndrome as compared with traditional intravascular ultrasound-based definitions. Prospective studies are needed to determine whether the use of all available quantitative plaque information provided by coronary computed tomography angiography may improve the detection of acute coronary syndrome and subsequently add value in clinical care.
All measurements were exported to an Excel file. Measurements performed at segments level were diameter stenosis (calculated as the ratio of the minimal luminal diameter in the coronary segment and the average of the luminal diameter at the proximal and distal references), MLA (luminal area at the site of maximum stenosis), plaque burden (calculated as plaque area divided by outer vessel area at the site of maximum stenosis), coronary plaque volume, plaque volume of subcomponents at <30 and <60 Hounsfield units (HU), lesion length (calculated as the centerline distance from the proximal to distal end of the plaque), and RI (calculated as the ratio of the outer vessel wall area at the site of the MLA and the vessel area defined by the vessel wall reference at that location). We also calculated relative plaque volume of low HU plaque at <30 and <60 HU, defined as the ratio between the volume of plaque subcomponents at <30 or <60 HU and the volume of the entire plaque.
Detection of Culprit Plaque
We detected culprit coronary plaque in patients with diagnosis of ACS during the index hospitalization. The diagnosis of ACS (acute myocardial infarction or unstable angina pectoris) was determined by an external, independent clinical end point committee according to the American College of Cardiology/American Heart Association guidelines and was previously described. 15 To identify the culprit lesions in patients with ACS, an independent investigator reviewed all available clinical data and reports, including additional cardiac testing (eg, invasive coronary angiography, stress echocardiograms, nuclear myocardial perfusion stress tests). The primary decision on the location of culprit lesions was made on the basis of ICA reports. ICA was performed in 32 of 37 patients with ACS. We assigned the culprit lesion to coronary segments, in which percutaneous coronary intervention was performed. In patients who underwent coronary artery by-pass grafting (n=4), we assigned culprit lesions to all segments with ≥70% stenosis or ≥50% stenosis for the left main coronary artery. Six patients underwent ICA without revascularization. The culprit lesion in those patients was assigned to the coronary segment with the highest degree of diameter stenosis on ICA. Patients not undergoing ICA (n=5) were excluded from this analysis because the culprit lesion could not be clearly defined.
Analysis of HRP Feature Definitions
We performed a per segment analysis to determine the CTAbased quantitative plaque measurements that are associated with culprit lesions in patients with ACS. In each patient with ACS, we analyzed each plaque feature for each segment with plaque (MLA, RI, plaque burden, lesion length, absolute and relative plaque volume of low HU plaque at <30 and <60 HU, and diameter stenosis). The results were reported at segment level. To determine differences in quantitative plaque measurements, we compared culprit plaque to all nonculprit plaques in patients with ACS.
For the diagnostic performance analysis of traditional IVUS thresholds for HRP features to detect patients with ACS, we used MLA ≤4.0 mm 2 , 7-10 RI >1.05 11, 12 and RI >1.1, plaque burden ≥70%, 7 lesion length ≥11.2 mm, 7 and volume of plaque <30 HU attenuation as TCFA equivalent as low attenuation plaque <30 HU was shown to qualitatively correspond to a lipid-rich necrotic core on coronary CTA. 5, [21] [22] [23] For the volume of low HU plaque, we used a derived, CTA-specific threshold of 1.31 mm3 because there is no equivalent definition based on IVUS. Thresholds from invasive angiography were used for diameter stenosis (≥50% or ≥70%).
To derive optimized CTA-specific HRP definitions, we used receiver operating characteristic curves of plaque measures to identify the maximum of the sum for sensitivity and specificity to discriminate culprit plaque from nonculprit plaque. Culprit plaque-based thresholds were then applied to all patients (with and without ACS) to identify the presence of any plaque feature above the respective culprit plaque-based thresholds on per patient basis and subsequently calculate the diagnostic performance for the detection of ACS. Diagnostic performance of the newly derived thresholds was then compared with above-mentioned traditional thresholds from IVUS in a dichotomized fashion.
Statistical Analysis
Continuous data are presented as mean±SD or median with 25th and 75th percentile, and categorical or ordinal variables are presented as absolute and relative frequencies. On a per patient level, comparisons between groups were performed with an independent Student t test or the Wilcoxon rank-sum test for continuous variables, Fisher exact test for categorical variables, and Wilcoxon rank-sum test for ordinal variables. On a segmental level, comparisons between groups were performed using univariable multilevel mixed-effects logistic regression models that account for the group structure (ie, multiple segments per patient) and thus possible autocorrelation effects in the data. To evaluate interobserver agreement among 4 readers, intraclass correlation coefficient (ICC) was calculated using 2-way random-effects models. To determine colinearities among all HRP features, we assessed Spearman rank correlation coefficients (CCs). Uni-and multivariable multilevel mixedeffects logistic regression analyses were performed to identify determinants for culprit lesion within patients with ACS and determinants for ACS among all patients. In the multivariable model, we included RI, MLA (mm 2 ), plaque burden (%), TCFA equivalent-low HU plaque volume <30 HU (mm 3 ), and lesion length. The discriminatory capacity of the dichotomized HRP thresholds for the prediction of culprit lesion and ACS was assessed using the area under curve (AUC). 27 Multivariable logistic regression models were used to calculate receiver operating characteristic curves. A 2-tailed P<0.05 was considered statistically significant. All statistical analyses were performed using Stata 13.1 (Stata-Corp LP, College Station, TX). The complete source data from the ROMICAT) II trial are publicly available in accordance with the data sharing policy of the National Institutes of Health and can be used for the purposes of reproducing the results or replicating the procedures.
RESULTS
Study Population
In the ROMICAT II trial, 501 patients were randomly assigned to the coronary CTA arm of the study and 472 of them underwent coronary CTA as the first test. Quantitative plaque analysis was performed in 255 patients (mean age, 56±7.8 years; 62.7% men), in whom coronary artery plaque was visually identified. ACS was diagnosed in 32 (6.8%) patients (myocardial infarction n=5, unstable angina pectoris n=32), 203 patients were adjudicated as noncardiac chest pain, 3 as noncoronary cardiac chest pain, and 17 as cardiac chest pain not meeting ACS criteria. Baseline characteristics are summarized in Table 1 . as continuous measures, also showed significant differences between culprit and nonculprit plaques as summarized in Table 2 (all P<0.01).
Interobserver Variability of Quantitative Coronary Plaque Analysis
Association of HRP Characteristics With Culprit Plaques of ACS
To determine which HRP features are associated with ACS using IVUS definitions, we used prespecified dichotomized IVUS thresholds for this analysis. We found that all HRP features, except remodeling index, were significantly associated with culprit plaques in a univariable analysis among 207 coronary plaques within 32 patients with ACS , as summarized in Table 3A . In a multivariable model, we found independent associations only for dichotomized thresholds of low HU plaque volume (odds ratio, 6.60; 95% CI, 2.52-17.24; P<0.001) and plaque burden (odds ratio, 3.14; 95% CI, 1.06-9.25; P=0.038). Using a predefined RI of 1.05 instead of 1.10 as above showed similar results (Table IIA in the Data Supplement).
We also found close correlations among HRP features, as listed in Table III 
Association of Traditional HRP Definitions (IVUS) With ACS
On a patient level, using dichotomized IVUS thresholds, MLA, plaque burden, lesion length, and low HU plaque volume were independently associated with ACS as displayed in Table 3B but not RI (odds ratio, 0.78; 95% CI, 0.25-2.45; P=0.673). Similar results were found using a RI of 1.05 instead of 1.10 (Table IIB in the Data Supplement).
The overall diagnostic performance of dichotomized IVUS thresholds ranged from good to very good ( Table 4 ). The probability of ACS associated with the presence of plaque that were characterized as low HU (TCFA equivalent) increased according to the additional presence of plaque burden ≥70% and MLA ≤4.0 mm 2 , from 25.3% to 69.9.0%, respectively (Figure 2 ). The presence of plaque burden ≥70% (AUC: 0.791; 95% CI, 0.711-0.872) and MLA ≤4.0 mm 2 (AUC: 0.865; 95% CI, 0.792-0.919) was associated with higher discriminatory capacity to detect ACS beyond TCFA equivalent (AUC: 0.725; 95% CI, 0.652-0.800), as displayed in Figure 3 (P=0.0082 and P=0.0190, respectively) .
HRP Definitions Optimized for Coronary CTA in Comparison to IVUS-Based Thresholds
Optimized quantitative HRP definitions for coronary CTA showed the maximum of the sum of sensitivity and specificity for the following thresholds: 1.17 for RI, 1.43 mm 2 for MLA, 55% for plaque burden, 1.31 mm 3 for low HU plaque volume, 52% for diameter stenosis, and 13.09 mm for lesion length.
The diagnostic performance of new derived thresholds was high as listed in Table 4 (more details in Table IV in the Data Supplement). Compared with traditional IVUS thresholds, optimized thresholds showed significantly higher diagnostic performance for plaque burden (AUC: 0.832; 95% CI, 0.768-0.896 versus 0.676; 95% CI, 0.591-0.762; P<0.001) and borderline significant performance for MLA (AUC: 0.817; 95% CI, 0.736-0.898 versus 0.742; 95% CI, 0.689-0.796; P=0.066) but not for RI and lesion length. There was also a significant difference in diameter stenosis using the optimized threshold of 52% as compared with ≥70% (AUC: 0.826; 95% CI, 0.743-0.908 versus 0.721; 95% CI, 0.632-0.810; P=0.005). Overall high discriminatory capacity was also seen for the threshold of low HU plaque volume (AUC: 0.725; 95% CI, 0.646-0.804). Lesion length calculated as the centerline distance from the proximal to distal end of the plaque. Remodeling index calculated as the ratio of the outer vessel wall area at the site of the minimal luminal area and the vessel area defined by the vessel wall reference at that location; plaque burden (plaque area in % of the total vessel area derived from a cross-sectional view). HU indicates Hounsfield units; IVUS, intravascular ultrasound; Q1;Q3, 25th percentile, 75th percentile; and TCFA, thin cap fibroatheroma.
The above-mentioned higher discriminatory capacity of the new derived thresholds for plaque burden and diameter stenosis translated into a significant improvement of the net reclassification index as shown in Table 4 .
The presence of multiple HRP features in 1 patient (low HU plaque volume, MLA, and plaque burden) showed high discriminatory capacity to detect ACS, using dichotomous prespecified IVUS definitions as well as optimized CTA-specific definitions (AUC: 0.856; 95% CI, 0.792-0.919 versus 0.900; 95% CI, 0.824-0.956; P=0.235). Using all available information from quantitative coronary CTA assessment (low-density plaque, MLA, plaque burden, RI, diameter stenosis, and lesion length), optimized CTA definitions showed an increase in the diagnostic performance (AUC: 0.856; 95% CI, 0.792-0.919 versus 0.932; 95% CI, 0.859-0.979; P=0.021) as visualized in Figure 4 .
DISCUSSION
Our study confirmed previous observations of differences in atherosclerotic plaque characteristics between culprit and nonculprit plaques. We demonstrated that HRP thresholds based on IVUS definitions had adequate performance to detect ACS using quantitative plaque analysis in coronary CTA. Moreover, this is the first multicenter study that independently derived optimized coronary CTA-specific HRP definitions, demonstrating significant differences and higher accuracy to traditional IVUS-based definitions.
Diagnostic Performance of IVUS-Based Thresholds in Coronary CTA
The PROSPECT trial (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) is a prospective natural history study demonstrating that MLA and plaque burden, as detected by IVUS, were among the strongest predictors for future major cardiovascular events in previously not culprit plaque. In IVUS, MLA ≤4.0 mm 2 and plaque burden ≥70.0% were associated with an >3-and 5-fold increased risk for future events, respectively (both P<0.001). We demonstrated similar strength of association with ACS in our study. MLA was associated with ≈7-fold and plaque burden with ≈6-fold increased risk of ACS using IVUS-based thresholds for quantitative coronary CTA analysis. In addition, we saw incremental value of these dichotomous thresholds beyond the presence of plaque that was characterized as low HU (TCFA equivalent) in coronary CTA.
In contrast, RI was found to be the weakest predictor of ACS in our analysis. In a multivariate model, it was neither independent nor incremental in the detection of ACS, potentially because of existing colinearities with other HRP features. Notably, this is in line with results from the PROSPECT trial, 7 where RI was also not an independent determinant for future cardiac events. *A remodeling index of ≥1.1, an MLA of ≤4.0 mm 2 , a plaque burden of ≥70%, and a lesion length of ≥11.2 mm were prespecified for use in this model because they have been used frequently in previous studies. For low HU plaque, a prespecified HU threshold of <30 HU was used as TCFA equivalent because it corresponds to a necrotic core in IVUS. For the volume of low HU plaque, we used the newly derived CTA-specific threshold of 1.31 mm 3 because there is no frequently used definition for plaque volume in IVUS. CTA indicates computed tomography angiography; HU, Hounsfield units; IVUS, intravascular ultrasound; MLA, minimal luminal area; and OR, odds ratio; and TCFA, thin-cap fibroatheroma.
Comparison of Traditional IVUS and Coronary CTA-Derived Thresholds
Similar to IVUS, optimized CTA definitions for MLA and plaque burden showed the strongest association to ACS in our analysis. However, differences in quantitative thresholds exist. In particular, the diagnostic performance of plaque burden was significantly higher using a threshold of 55% versus the IVUS threshold of 70% (P<0.001). This finding is in line with data from Versteylen et al. 26 In this retrospective analysis, including 25 patients with ACS and 101 controls, who underwent coronary CTA and semiautomated plaque quantification, a plaque burden of 45% provided the highest sum of sensitivity and specificity. The lower spatial resolution of computed tomography and subsequent underestimation of noncalcified plaque volume in coronary computed tomography might account for this discrepancy. 28 As mentioned before, an MLA of ≤4.0 mm 2 was associated with a significantly higher likelihood for recurrent events in IVUS (hazard ratio: 3.21; P=0.001), 7 and in patients with lesions >4.0 mm 2 , intervention could be deferred safely. 8 In contrast, for coronary CTA, a threshold of 1.43 mm 2 showed a borderline significant higher diagnostic performance (P=0.066) to discriminate patients with ACS. Our result is similar to the cutoff found in a recently published prospective analysis of 160 patients, in which an MLA ≤1.8 mm 2 in coronary CTA was shown to be most accurate for the prediction of hemodynamically significant stenosis by ICA and fractional flow reserve. 29 Technical requirements may potentially explain discrepancies between CTA and IVUS because IVUS is usually limited to proximal and middle portions of epicardial vessels, but no restrictions were applied to coronary CTA data sets in our study, except exclusions because of nondiagnostic image quality (<3%). Because of the ability to determine MLA even in peripheral vessels and side branches using coronary CT plaque quantification, the reference vessel area at the site of each individual lesion of interest has to be to be taken into account. The proposed optimized threshold of 1.43 mm 2 can certainly not be used individually for patients with, Remodeling index calculated as the ratio of the outer vessel wall area at the site of the minimal luminal area and the vessel area defined by the vessel wall reference at that location; plaque burden (plaque area in % of the total vessel area derived from a cross-sectional view); lesion length calculated as the centerline distance from the proximal to distal end of the plaque. ACS indicates acute coronary syndrome; AUC, area under the curve (in respect to the dichotomized threshold); CTA, computed tomography angiography; HU, Hounsfield units; IVUS, intravascular ultrasound; NRI, net reclassification index; and TCFA, thin-cap fibroatheroma.
*Improvement of coronary CTA-derived thresholds compared with IVUS-derived thresholds for the prediction of ACS. P values indicate difference between †IVUS and ‡CT AUCs.
for example, left main or proximal left anterior descending coronary artery disease, indicating the need for more granular information with respect to valid MLA reference values also for medium and small vessels. Whether indexing the lesion-specific MLA to the reference vessel might be an adequate solution to address this aspect will need to be tested in future analysis. In addition, above-mentioned IVUS data demonstrated the association of MLA with mid-and long-term risk for subsequent cardiovascular events in previously nonculprit lesions while the underlying quantitative coronary CTA assessment aimed to optimize HRP definitions for the immediate diagnosis of ACS according to culprit lesions. MLA was consistent with degree of stenosis in our analysis, and as the diagnosis of ACS was predominately driven by obstructive coronary artery disease in this acute chest pain cohort, MLA might, therefore, differ from the traditional threshold.
TCFA, as detected by IVUS, has been also shown to be a strong predictor of future cardiovascular events. 7 Qualitatively, low HU plaque (<30 HU) and Napkin-Ring Sign correspond to a lipid-rich necrotic core in coronary CTA. 5, [21] [22] [23] Beyond that, we could now demonstrate that quantitative assessment of low HU plaque volume is not only independently associated with culprit plaque in patients with ACS but also with ACS among all patients with coronary plaque. The volume threshold of 1.31 mm 3 provides good sensitivity, high negative predictive value (96%), and good diagnostic accuracy to discriminate patients with ACS from those without ACS. Thus, this CTA-specific definition seems to be a reasonable threshold for quantitative plaque analysis and adds more granular information beyond the attenuation threshold of 30 HU. This might be useful because coronary CTA is already a viable modality to approach patients with suspected ACS [15] [16] [17] and may become the main noninvasive diagnostic test for the assessment of HRP features. 
New CTA-Based Measures of HRP
One plaque characteristic that has been paid little attention to in coronary CTA to date is lesion length, which has previously not only been shown to differ between ACS and non-ACS patients 6 but also to be a strong determinant of hemodynamic relevant stenosis 30 improving the correlation of functional assessment and anatomic severity as demonstrated by fractional flow reserve. 31 In fact, our analysis showed that lesion length was significantly higher in culprit plaque as compared with nonculprit plaque (P<0.001) and was independently associated with ACS in patients with coronary plaque. This translated to a good diagnostic performance (AUC, 0.8) for this individual HRP feature. A potential explanation for the independent value of lesion length is that few HRP features account for longitudinal plaque dimensions.
These data suggest that the use of all available quantitative plaque information provided by coronary CTA, including lesion length, may further improve the detection of ACS and should therefore be considered in future analysis to better allow for determining its clinical value in prospective studies.
Limitations
Some limitations of this study need to be mentioned. First, quantitative coronary plaque assessment is time consuming and requires substantial readers expertise albeit a semiautomated software was used. Improvements in software algorithm are needed to further facilitate measurements and demonstrate feasibility for the use in clinical routine. Second, because of a limited incidence of disease (ACS: n=32), small differences in definitions for HRP features might not be apparent even though the overall number of patient included in this analysis was substantial. Third, in this cohort, we focused on the immediate diagnosis of ACS for the derivation of coronary CTA-specific HRP definitions. Although IVUS definitions in PRSOPECT trial were used to predict future events, similar definitions were also shown to be present in patients with immediate diagnosis of ACS. 32 Validation of these new definitions will be necessary in an independent cohort, and we further need to determine whether these can also improve midand long-term predictions of ACS and major adverse cardiovascular events.
Conclusions
Marked differences in plaque extent and morphology are present comparing culprit and nonculprit plaques in patients experiencing ACS. We could demonstrate significant differences and higher accuracy of independently derived optimized coronary CTA-specific HRP definitions, suggesting improvement in discrimination of patients with ACS, as compared with traditional IVUS-based definitions. 
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